First Sabrepoint Capital Management LP Turning Point Therapeutics, Inc. Transaction History
First Sabrepoint Capital Management LP
- $235 Million
- Q3 2024
About Turning Point Therapeutics, Inc.
- Ticker TPTX
- Exchange NASDAQ
- Shares Outstandng 50,074,300